Onesource Specialty Pharma Achieves 'Leader' ESG Rating of 73 for FY25
Onesource Specialty Pharma Ltd has received an Environmental, Social, and Governance (ESG) Rating of '73' from NSE Sustainability Ratings & Analytics Limited. The assignment positions the company in the 'Leader' rating category for the financial year FY25.NSE Sustainability Ratings & Analytics Limited independently assigned the ESG rating to Onesource Specialty Pharma Ltd. The rating was based on information pertaining to the company’s performance for the financial year FY25, which was available in the public domain.
The specialized rating by NSE Sustainability highlights the company's standing across key ESG parameters.
Below are the material details of the ESG Rating assigned to Onesource Specialty Pharma Ltd:
| Parameter | Detail |
|---|---|
| Company | Onesource Specialty Pharma Ltd |
| Rating Agency | NSE Sustainability Ratings & Analytics Limited |
| Financial Year | FY25 |
| ESG Rating | 73 |
| Rating Category | Leader |
This independent rating provides insight into Onesource Specialty Pharma Ltd's performance regarding its environmental, social, and governance practices during the fiscal year 2025.
ONESOURCE Stock Price Movement
As of 10:15 AM, shares of Onesource Specialty Pharma Limited are shedding 2.80% in live trading, currently holding at ₹1495. The stock traded on a significant volume of 105,544 shares during the current market session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.